ReP USP - Resultado da busca

Artigo de periodico
Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe (2020)
Caris, Juciene Aparecida ; Benzi, Jhohann Richard de Lima ; Souza, Flávio Falcão Lima de; Oliveira, Renê Donizeti Ribeiro de; Donadi, Eduardo Antônio ; Lanchote, Vera Lucia
Source: European Journal of Pharmaceutical Sciences. Unidades: FMRP, FCFRP
Subjects: ARTRITE REUMATOIDE, METABOLISMO, ESTUDOS DE CASOS E CONTROLES, CITOCROMO P-450, ESTATINAS, NECROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARIS, Juciene Aparecida et al. Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe. European Journal of Pharmaceutical Sciences, v. 146, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105264. Acesso em: 16 nov. 2024.
APA
Caris, J. A., Benzi, J. R. de L., Souza, F. F. L. de, Oliveira, R. D. R. de, Donadi, E. A., & Lanchote, V. L. (2020). Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe. European Journal of Pharmaceutical Sciences, 146, 1-7. doi:10.1016/j.ejps.2020.105264
NLM
Caris JA, Benzi JR de L, Souza FFL de, Oliveira RDR de, Donadi EA, Lanchote VL. Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 146 1-7.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ejps.2020.105264
Vancouver
Caris JA, Benzi JR de L, Souza FFL de, Oliveira RDR de, Donadi EA, Lanchote VL. Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 146 1-7.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ejps.2020.105264
Artigo de periodico
Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers (2020)
Cestari, Roberta Natália ; Caris, Juciene Aparecida ; Rocha, Adriana; Nardotto, Glauco Henrique Balthazar ; Oliveira, Renê Donizeti Ribeiro de; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: ESTATINAS, FARMACOCINÉTICA, FARMACOLOGIA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, COMPOSTOS ORGÂNICOS, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESTARI, Roberta Natália et al. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, v. 182, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113128. Acesso em: 16 nov. 2024.
APA
Cestari, R. N., Caris, J. A., Rocha, A., Nardotto, G. H. B., Oliveira, R. D. R. de, & Lanchote, V. L. (2020). Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, 182, 1-7. doi:10.1016/j.jpba.2020.113128
NLM
Cestari RN, Caris JA, Rocha A, Nardotto GHB, Oliveira RDR de, Lanchote VL. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 182 1-7.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jpba.2020.113128
Vancouver
Cestari RN, Caris JA, Rocha A, Nardotto GHB, Oliveira RDR de, Lanchote VL. Plasma mevalonic acid exposure as a pharmacodynamic biomarker of fluvastatin/atorvastatin in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 182 1-7.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jpba.2020.113128
Artigo de periodico
Systemic Lupus Erythematosus activity affects the sinusoidal uptake transporter OATP1B1 evaluated by the pharmacokinetics of Atorvastatin (2020)
Cestari, Roberta Natália ; Oliveira, Renê Donizeti Ribeiro de; Souza, Flávio Falcão Lima de; Pippa, Leandro Francisco ; Nardotto, Glauco Henrique Balthazar ; Rocha, Adriana; Donadi, Eduardo Antônio ; Lanchote, Vera Lucia
Source: Clinical and Translational Science. Unidades: FMRP, FCFRP
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, FARMACOCINÉTICA, FÁRMACOS, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESTARI, Roberta Natália et al. Systemic Lupus Erythematosus activity affects the sinusoidal uptake transporter OATP1B1 evaluated by the pharmacokinetics of Atorvastatin. Clinical and Translational Science, v. 13, n. 6, p. 1227-1235, 2020Tradução . . Disponível em: https://doi.org/10.1111/cts.12808. Acesso em: 16 nov. 2024.
APA
Cestari, R. N., Oliveira, R. D. R. de, Souza, F. F. L. de, Pippa, L. F., Nardotto, G. H. B., Rocha, A., et al. (2020). Systemic Lupus Erythematosus activity affects the sinusoidal uptake transporter OATP1B1 evaluated by the pharmacokinetics of Atorvastatin. Clinical and Translational Science, 13( 6), 1227-1235. doi:10.1111/cts.12808
NLM
Cestari RN, Oliveira RDR de, Souza FFL de, Pippa LF, Nardotto GHB, Rocha A, Donadi EA, Lanchote VL. Systemic Lupus Erythematosus activity affects the sinusoidal uptake transporter OATP1B1 evaluated by the pharmacokinetics of Atorvastatin [Internet]. Clinical and Translational Science. 2020 ; 13( 6): 1227-1235.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/cts.12808
Vancouver
Cestari RN, Oliveira RDR de, Souza FFL de, Pippa LF, Nardotto GHB, Rocha A, Donadi EA, Lanchote VL. Systemic Lupus Erythematosus activity affects the sinusoidal uptake transporter OATP1B1 evaluated by the pharmacokinetics of Atorvastatin [Internet]. Clinical and Translational Science. 2020 ; 13( 6): 1227-1235.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/cts.12808
Artigo de periodico
Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose (2019)
Cestari, Roberta Natália; Rocha, Adriana; Marques, Maria Paula ; Oliveira, Renê Donizeti Ribeiro de; Lanchote, Vera Lucia
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP
Subjects: ESTATINAS, METABÓLITOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESTARI, Roberta Natália et al. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose. Journal of Chromatography B, v. 1126-1127, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2019.121766. Acesso em: 16 nov. 2024.
APA
Cestari, R. N., Rocha, A., Marques, M. P., Oliveira, R. D. R. de, & Lanchote, V. L. (2019). Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose. Journal of Chromatography B, 1126-1127. doi:10.1016/j.jchromb.2019.121766
NLM
Cestari RN, Rocha A, Marques MP, Oliveira RDR de, Lanchote VL. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose [Internet]. Journal of Chromatography B. 2019 ; 1126-1127[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jchromb.2019.121766
Vancouver
Cestari RN, Rocha A, Marques MP, Oliveira RDR de, Lanchote VL. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose [Internet]. Journal of Chromatography B. 2019 ; 1126-1127[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jchromb.2019.121766

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em